Effects of the augmenter of liver regeneration on the biological behavior of hepatocellular carcinoma

Saudi Medical Journal

Volumn 30, Issue 8, 2009, Pages 1001-1009

  Tang, Lin ^a   Sun, Hang ^a   Zhang, Lin ^a   Deng, Jian C ^a   Guo, Hui ^a   Zhang, Ling ^a   Liu, Qi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUGMENTER OF LIVER REGENERATION; DNA; GROWTH FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER REGENERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LIVER REGENERATION; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 70349488193     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: Expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994; 91: 8142-8146.
2. Hagiya M, Francavilla A, Polimeno L, Ihara I, Sakai H, Seki T, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: Expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1995; 92: 3076.
3. Yang XM, Xie L, Qiu ZH, Gong F, Wu ZZ, He FC. cDNA clone, expression and biological activity study of augmenter of liver regeneration. Shengwu Huaxue Zazhi 1997; 13: 130-135.
4. Yang X, Wang A, Zhou P, Wang Q, Wei H, Wu Z, et al. Protective effect of recombinant human augmenter of liver regeneration on CCl4-induced hepatitis in mice. Chin Med J (Engl) 1998; 111: 625-629.
5. Thirunavukkarasu C, Wang LF, Harvey SA, Watkins SC, Chaillet JR, Prelich J, et al. Augmenter of liver regeneration: An important intracellular survival factor for hepatocytes. J Hepatol 2008; 48: 578-588.
6. Polimeno L, Capuano F, Marangi LC, Margiotta M, Lisowsky T, Ierardi E, et al. The augmenter of liver regeneration induces mitochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mitochondria. Dig Liver Dis 2000; 32: 510-517.
7. Wang AM, Yang XM, Guo RF, Zhang L, Li PJ, Wang QM, He FC. The recombinant augmenter of liver regeneration reverse fibrosis in experimental rat. Zhonghua Ganzangbing Zazhi 1999; 7: 243.
8. Wang AM, Yang XM, Guo RF, Zhang L, Li PJ, Wang QM, He FC. Effect of recombinant human augmenter of liver regeneration on gene expression of tissue inhibitor of metalloproteinase-1 in rat with experimental liver fibrosis. Zhonghua Yixue Zazhi 2002; 82: 610-612.
9. Francavilla A, Vujanovic NL, Polimeno L, Azzarone A, Iacobellis A, Deleo A, et al. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997; 25: 411-415.
10. Tanigawa K, Sakaida I, Masuhara M, Hagiya M, Okita K. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol 2000; 35: 112-119.
11. Polimeno L, Margiotta M, Marangi L, Lisowsky T, Azzarone A, Ierardi E, et al. Molecular Mechanisms of augmenter of liver regeneration as immunoregulator: Its effect on interferon-gamma expression in rat liver. Dig Liver Dis 2000; 32: 217-225.
12. Adams GA, Maestri M, Squiers EC, Alfrey EJ, Starzl TE, Dafoe DC. Augmenter of liver regeneration enhances the success rates of fetal pancreas transplantation in rodents. Transplantation 1998; 65: 32-36.
13. Zhang Lin, Liao Xiaohui, Liu Qi. Expression and significance of augmenter of liver regeneration in rat renal tissue with gentamicin-induced acute renal failure. Chongqing Yixue 2003; 32: 647-649.
14. Li C, Hong-Liu S, Wei A. Increased cellular proliferation and protection of recombined human hepatic stimulator substance. Jiepou Xuebao 2003; 34: 155-158.
15. Yang XM, Hu XY, Xie L, Wu ZZ, He FC. In vitro stimulation of HTC hepatoma cell growth by recombinant human augmenter of liver regeneration (ALR). Sheng Li Xue Bao 1997; 49: 557-561.
16. Thasler WE, Schlott T, Thelen P, Hellerbrand C, Bataille F, Lichtenauer M, et al. Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma. Histopathology 2005; 47: 57-66.
17. Liu Q, Yu HF, Sun H, Ma HF. Expression of human augmenter of liver regeneration in Pichia pastoris yeast and its bioactivity in vitro. World J Gastroenterol 2004; 10: 3188-3190.
18. Sun H, Yu HF, Wu CX, Guan XQ, Liu Q. Expression of augmenter of liver regeneration in hepatic tumor cells and its clinical significance. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 205-208.
19. Wang G, Yang X, Zhang Y, Wang Q, Chen H, Wei H, et al. Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1. J Biol Chem 1999; 274: 11469-11472.
20. Ma HF, Liu Q. Preparation of monoclonal antibody to human augmenter of liver regeneration: Screening of hybridomas with unpurified antigen expressed by E.coli. Zhongguo Mianyixue Zazhi 2002; 18: 671-673.
21. Xu XM, Chen Y, Chen J, Yang S, Gao F, Underhill CB, et al. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis. Cancer Res 2003; 63: 5685-5690.
22. Badvie S. Hepatocellular carcinoma. Postgrad Med J 2000; 76: 4-11.
23. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454.
24. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 2000; 191: 381-388.
25. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial. Lancet 2000; 356: 802-807.
26. Huang YH, Wu JC, Lui WY, Chau GY, Tsay SH, Chiang JH, et al. Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World J Surg 2000; 24: 551-555.
27. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 10-24.
28. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
29. Wall NR, Shi Y. Small RNA: Can RNA interference be exploited for therapy? Lancet 2003; 362: 1401-1403.
30. Kumari A, Srinivasan R, Wig JD. Effect of c-MYC and E2F1 gene silencing and of 5-azacytidine treatment on telomerase activity in pancreatic cancer-derived cell lines. Pancreatology 2009; 9: 360-368.
31. Gu W, Cochrane M, Leggatt GR, Payne E, Choyce A, Zhou F, et al. Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses. Proc Natl Acad Sci U S A 2009; 106: 8314-8319
32. Crowder RJ, Phommaly C, Tao Y, Hoog J, Luo J, Perou CM, et al. PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer. Cancer Res 2009; 69: 3955-3962.
33. Lu C, Li Y, Zhao Y, Xing G, Tang F, Wang Q, et al. Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway. FASEB J 2002; 16: 90-92.